Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy

BACKGROUND: The aim of this study was to investigate the efficacy of bevacizumab (Bev) in reducing peritumoral brain edema (PTBE) after stereotactic radiotherapy (SRT) for lung cancer brain metastases. METHODS: A retrospective analysis was conducted on 44 patients with lung cancer brain metastases (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Yi‐Chun, Gao, De‐Zhi, Wang, Kuan‐Yu, Ding, Xiao‐Sheng, Xu, Wei‐Ran, Li, Yu‐Bin, Shi, Wei‐Wei, Sun, Shi‐Bin, Li, Xiao‐Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626225/
https://www.ncbi.nlm.nih.gov/pubmed/37718465
http://dx.doi.org/10.1111/1759-7714.15106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626225/
https://www.ncbi.nlm.nih.gov/pubmed/37718465
http://dx.doi.org/10.1111/1759-7714.15106

Ejemplares similares